Work

Patient-reported outcomes of patients with advanced renal cell carcinoma (aRCC) treated with first-line nivolumab plus cabozantinib versus sunitinib: The CheckMate 9ER trial.

Year: 2021

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2021.39.6_suppl.285

Authors: David Cella, Toni K. Choueiri, Steven I. Blum, Flavia Ejzykowicz, Melissa Hamilton, Joshua Zhang, Cristina Ivanescu, Robert J. Motzer

Institutions: Northwestern University, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Dana-Farber Cancer Institute, Bristol-Myers Squibb (United States), Memorial Sloan Kettering Cancer Center

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3135469022

Cites:

Cited by: 14

Related to: 10